Literature DB >> 1893317

Periodic health examination, 1991 update: 4. Screening for cystic fibrosis. Canadian Task Force on the Periodic Health Examination.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1893317      PMCID： PMC1335767     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  37 in total

1.  Identification of the cystic fibrosis gene: genetic analysis.

Authors:  B Kerem; J M Rommens; J A Buchanan; D Markiewicz; T K Cox; A Chakravarti; M Buchwald; L C Tsui
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

2.  Effects of social class, sex, and region of residence on age at death from cystic fibrosis.

Authors:  J R Britton
Journal:  BMJ       Date:  1989-02-25

Review 3.  The cystic fibrosis gene.

Authors:  P J Scambler
Journal:  Arch Dis Child       Date:  1989-12       Impact factor: 3.791

4.  Chronic disease and its impact. The adolescent's perspective.

Authors:  M Cappelli; P J McGrath; C E Heick; N E MacDonald; W Feldman; P Rowe
Journal:  J Adolesc Health Care       Date:  1989-07

5.  Cystic fibrosis in adult life: a study of coping patterns.

Authors:  P Pinkerton; T Trauer; F Duncan; M E Hodson; J C Batten
Journal:  Lancet       Date:  1985-10-05       Impact factor: 79.321

6.  Recent developments in neonatal screening.

Authors:  E W Naylor
Journal:  Semin Perinatol       Date:  1985-04       Impact factor: 3.300

7.  Reduced morbidity in patients with cystic fibrosis detected by neonatal screening.

Authors:  B Wilcken; G Chalmers
Journal:  Lancet       Date:  1985-12-14       Impact factor: 79.321

8.  Role of conventional physiotherapy in cystic fibrosis.

Authors:  J J Reisman; B Rivington-Law; M Corey; J Marcotte; E Wannamaker; D Harcourt; H Levison
Journal:  J Pediatr       Date:  1988-10       Impact factor: 4.406

9.  Short-term nutritional supplementation during management of pulmonary exacerbations in cystic fibrosis: a controlled study, including effects of protein turnover.

Authors:  R W Shepherd; T L Holt; G Cleghorn; L C Ward; A Isles; P Francis
Journal:  Am J Clin Nutr       Date:  1988-08       Impact factor: 7.045

10.  Oral ciprofloxacin compared with conventional intravenous treatment for Pseudomonas aeruginosa infection in adults with cystic fibrosis.

Authors:  M E Hodson; C M Roberts; R J Butland; M J Smith; J C Batten
Journal:  Lancet       Date:  1987-01-31       Impact factor: 79.321
View more
  1 in total

1.  Association between use of systematic reviews and national policy recommendations on screening newborn babies for rare diseases: systematic review and meta-analysis.

Authors:  Sian Taylor-Phillips; Chris Stinton; Lavinia Ferrante di Ruffano; Farah Seedat; Aileen Clarke; Jonathan J Deeks
Journal:  BMJ       Date:  2018-05-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.